Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Consultas o comentarios: productividad@anid.cl
Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America
| Indexado |
|
||||
| DOI | 10.1016/J.JNS.2018.07.024 | ||||
| Año | 2018 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Abstract
Conclusions: The recommendations of these consensus guidelines attempt to optimize the health care and management of PPMS patients in LATAM.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Cristiano, Edgardo | Hombre |
HOSP ITALIANO BUENOS AIRES - Argentina
Instituto Universitario del Hospital Italiano de Buenos Aires - Argentina Hospital Británico de Buenos Aires - Argentina |
| 2 | Rojas, Juan Ignacio | Hombre |
HOSP ITALIANO BUENOS AIRES - Argentina
Instituto Universitario del Hospital Italiano de Buenos Aires - Argentina Hospital Británico de Buenos Aires - Argentina |
| 3 | Abad, Patricio | Hombre |
Hosp Metropolitan Quito - Ecuador
Hospital Metropolitano - Ecuador |
| 4 | Adoni, Tarso | - |
Hosp Sirio Libanes - Brasil
Hospital Sirio-Libanês - Brasil |
| 5 | Barahona, J | - |
Clin Alemana Santiago Chile - Chile
Clínica Alemana - Chile |
| 6 | Becker, Jefferson | Hombre |
Pontifica Catholic Univ Rio Grande Sul PUCRS - Brasil
Pontifica Universidade Católica do Rio Grande do Sul - Brasil |
| 7 | Carra, Adriana | Mujer |
Hosp Britan Buenos Aires - Argentina
INECO - Argentina Hospital Británico de Buenos Aires - Argentina Fundacion Favaloro - Argentina |
| 8 | Flores, Jose | Hombre |
Inst Nacl Neurol & Neurocirug - México
Ctr Neurol ABC Santa Fe - México Instituto Nacional de Neurología y Neurocirugía - México Medical Center ABC Santa Fe - México Centro Médico ABC Santa Fe - México |
| 9 | Fruns, Manuel | Hombre |
Clínica Las Condes - Chile
|
| 10 | Fernandez Liguori, Nora | Mujer |
Hosp Enrique Tornu - Argentina
Sanat Guemes - Argentina Tornu Hospital - Argentina Sanatorio Guemes - Argentina |
| 11 | Garcea, Orlando | Hombre |
Hosp Ramos Mejia - Argentina
Hospital J.M. Ramos Mejia, Buenos Aires - Argentina |
| 12 | Garcia Bonito, Juan | Hombre |
Sistema Nacl Salud Colombiano - Colombia
Sistema Nacional De Salud Colombiano - Colombia |
| 13 | Giunta, Diego H. | Hombre |
HOSP ITALIANO BUENOS AIRES - Argentina
Instituto Universitario del Hospital Italiano de Buenos Aires - Argentina Hospital Británico de Buenos Aires - Argentina |
| 14 | Gracia, Fernando | Hombre |
Univ Interamer Panama - Panamá
Universidad Interamericana de Panamá - Panamá |
| 15 | Hamuy, Fernando | Hombre |
Hosp IMT - Paraguay
Dept Neurol Diagnost Codas Thompson - Paraguay Hospital IMT - Paraguay Departamento de Neurologia de Diagnóstico Codas Thompson - Paraguay |
| 16 | Macias Islas, Miguel Angel | Hombre |
Univ Guadalajara - México
Universidad de Guadalajara - México |
| 17 | Navas, Cárlos | Hombre |
Clin Univ Colombia - Colombia
Clinica Enfermedad Desmielinizante Clinica Universitaria Colombia - Colombia |
| 18 | Ordonez Boschetti, Liliana | Mujer |
Hosp Espanol Mexico - México
Spanish Hospital, Mexico City - México |
| 18 | Boschetti, Liliana Ordoñez | Mujer |
Spanish Hospital, Mexico City - México
Hosp Espanol Mexico - México |
| 19 | Patrucco, Liliana | Mujer |
HOSP ITALIANO BUENOS AIRES - Argentina
Instituto Universitario del Hospital Italiano de Buenos Aires - Argentina Hospital Británico de Buenos Aires - Argentina |
| 20 | Sato, Douglas K. | Hombre |
Pontifica Catholic Univ Rio Grande Sul PUCRS - Brasil
Pontifica Universidade Católica do Rio Grande do Sul - Brasil |
| 21 | Correale, Jorge | Hombre |
FLENI - Argentina
Fundacion Para La Lucha Contra Las Enfermedades Neurologicas de La Infancia - Argentina |
| Fuente |
|---|
| Conselho Nacional de Desenvolvimento Científico e Tecnológico |
| Coordenação de Aperfeiçoamento de Pessoal de Nível Superior |
| Japan Society for the Promotion of Science |
| Ministry of Education, Culture, Sports, Science and Technology |
| Bayer |
| Merck |
| CAPES/Brasil |
| Shire |
| Roche |
| Biogen |
| CNPq/Brasil |
| Teva Pharmaceutical Industries |
| Merck-Serono and Quest/Athena Diagnostics |
| Euroimmun AG |
| BRASIL |
| Merck-Serono and Quest |
| Athena Diagnostics |
| Agradecimiento |
|---|
| EC has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. JIR has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. TA has received consulting fees, lecture honoraria and Travel Support from Biogen, Merck, Roche and Teva. JB has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Bayer, Biogen, Ipsen, Merck, Novartis, Roche, Sanofi, Teva. NFL has received consulting fees from Biogen, Novartis and Genzyme, as a lecturer from Merck Serono, Novartis and Biogen, and collaboration for attendance to national and international congresses from Biogen, Novartis, Merck Serono, Bayer and Gador. FG has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis, Bayer. FH has received consulting fees from Genzyme. MAMI has received reimbursement for dveleoping adboard activities for Sanofi-Genzyme Mexico. CN has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Stendhal, Roche, Biogen, Genzyme, Merck, Novartis, Biopas. LOB has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Novartis, Stendhal, Roche, Teva, Sanofi, Merck, Synthon. LP has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. JC has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. JB has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Bayer, Biogen, Ipsen, Merck, Novartis, Roche, Sanofi, Teva. DKS has received a scholarship from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; a Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI 15K19472); research support from CNPq/Brasil ( 425331/2016-4 ), CAPES/Brasil ( 88881.068012/2014-01 ), TEVA (research grant for EMOCEMP Investigator Initiated Study – NCT no. 61080516.4.1001.5336 ), and Euroimmun AG and speaker honoraria from Biogen, Novartis, Genzyme, TEVA, Merck, Roche, Bayer and participated in advisory boards from Shire, Roche, TEVA, Merck-Serono and Quest/Athena Diagnostics. OG has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. AC, JF, MF, JGB, DG has nothing to disclose. |
